A new U.N. AIDS agency report says the sudden withdrawal of U.S. funding has caused a “systemic shock” to the global effort ...

Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

Amid international aid cuts, we need renewed focus on our collective goal to bring HIV under control by 2030, write Linda-Gail Bekker and colleagues Since its inception in 2003, the US President’s ...

Lower-income countries will gain access to a "game-changing" HIV prevention drug with a new deal signed between US ...

Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...

Subang. In the Subang region of West Java, there are 6,000 men registered as members of the men who have sex with men (MSM) community. The Head of the Subang Health Department (Dinkes), Dr. Maxi, ...

UNAIDS emphasizes that every dollar invested in the HIV response not only saves lives but strengthens health systems and promotes broader development goals. Since the start of the epidemic, 26.9 ...

Gilead Sciences (GILD) stock in focus as the company joins The Global Fund to expand access to lenacapavir, an HIV PrEP ...

Rep. Marjorie Taylor Greene (R-GA) ranted about how the U.S. sends money to Africa to prevent the spread of HIV, arguing that ...

Congress just passed a sweeping bill that includes changes to Medicaid expected to cut millions of people with low incomes ...

Today, Pride is still an uprising. Keeping HIV awareness and prevention at the heart of Pride Month deepens its mission and ...